Crestwood Advisors Group LLC Novartis Ag Transaction History
Crestwood Advisors Group LLC
- $5.16 Billion
- Q4 2024
A detailed history of Crestwood Advisors Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 2,309 shares of NVS stock, worth $245,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,309
Previous 2,104
9.74%
Holding current value
$245,354
Previous $242,000
7.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,439Shares Held
135MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.3 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$860 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$742 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$613 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...